Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	54.33	548.51	355.41
Graham Fair Price	18.01	1.35	1.15
PEG	41.03	4.67	3.31
Price/Book	10.03	13.06	11.87
Price/Cash Flow	179.04	388.41	139.19
Prices/Earnings	5.77	116.78	110.41
Price/Sales	14.62	77.71	67.80
Price/FCF	179.04	388.41	139.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.57	0.82	0.82
Operating Margin	17.89	0.13	0.11
ROA	6.31	0.02	0.02
ROE	0.03	0.03	4.03
ROIC	0.02	0.02	19.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	-0.03	-84.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.65	0.23	-64.48
EPS QOQ	0.33	0.25	-25.00
FCF QOQ	1.25	-0.57	-54.15
Revenue QOQ	0.09	0.04	-52.49
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.31	0.00	inf
Days Sales Outstanding (DSO)	53.97	69.09	28.03
Inventory Turnover	293.62	0.00	inf
Debt/Capitalization	0.06	0.05	-12.18
Quick Ratio	5.41	5.80	7.17
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.47	1.71	15.70
Cash	1.56	1.75	12.13
Capex	< 0.005	< 0.005	41.61
Free Cash Flow	0.13	0.06	-54.38
Revenue	0.26	0.29	11.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.55	5.91	6.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.26	-3.40	35.45
Naive Interpretation	Member

06 - Financial Health · Bad

Rating